Bonyf N.V. Logo

Bonyf N.V.

Develops medical devices for oral, dental, orthodontic, and dermatological care.

MLBON | BR

Overview

Corporate Details

ISIN(s):
BE6333353298
LEI:
699400NGN0HE0QBIF505
Country:
Belgium
Address:
Doornzelestraat 114 bus D, 9000 Gent

Description

Bonyf N.V. is a company specializing in the research, development, production, and distribution of products for oral, dental, orthodontic, and dermatological care. The company develops clinically validated solutions for dental professionals, pharmacies, and consumers. Its portfolio includes care products for removable oral appliances such as dentures, retainers, and orthodontic devices. Key innovations are based on its patented NitrAdine® formulation, which is used in products like disinfecting tablets and PerioCream, a mucoadhesive paste for professional periodontal treatment. Bonyf focuses on providing high-quality, certified medical device solutions to improve patient well-being.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 15:23
bonyf AG receives the EU-MDR Certification Class IIa for PerioCream
English 19.5 KB
2025-09-15 17:28
bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Dusseldorf
English 16.3 KB
2025-09-05 10:51
bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developm…
English 15.3 KB
2025-08-11 15:16
Periocream: The Future Commercial Winner for bonyf
English 17.8 KB
2025-07-14 17:43
bonyf Reaffirms Its Long-Term Vision Amid Short-Term Market Volatility
English 21.7 KB
2025-06-30 21:18
Annual Results 2024
English 12.4 KB

Automate Your Workflow. Get a real-time feed of all Bonyf N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonyf N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonyf N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-15 Bogaert Jean-Pierre Executive member Sell 4,900 82,810.00 EUR
2025-05-01 Bogaert Jean-Pierre Executive member Sell 3,782 66,563.20 EUR
2025-03-06 Bogaert Jean-Pierre Executive member Sell 15,000 262,500.00 EUR
2025-02-26 Bogaert Jean-Pierre Executive member Sell 3,128 59,432.00 EUR
2025-02-21 Bogaert Jean-Pierre Executive member Sell 1,986 36,741.00 EUR
2025-02-13 Bogaert Jean-Pierre Executive member Sell 6,030 108,540.00 EUR
2025-02-12 Bogaert Jean-Pierre Executive member Sell 1,300 24,700.00 EUR
2024-12-30 Bogaert Jean-Pierre Executive member Sell 1,400 25,200.00 EUR
2024-12-20 Bogaert Jean-Pierre Executive member Sell 1,250 23,750.00 EUR
2024-12-17 Bogaert Jean-Pierre Executive member Sell 1,700 32,300.00 EUR

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.